Showing 241 - 260 results of 1,139 for search '"preclinical"', query time: 0.05s Refine Results
  1. 241

    Molecular Imaging Probes for Diagnosis and Therapy Evaluation of Breast Cancer by Qingqing Meng, Zheng Li

    Published 2013-01-01
    “…Molecular imaging has the potential to enhance our understanding of breast cancer biology and effects of drug action during both preclinical and clinical phases of drug development. …”
    Get full text
    Article
  2. 242

    The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination by Graham Skelhorne-Gross, Christopher J. B. Nicol

    Published 2012-01-01
    “…Despite extensive preclinical evidence that peroxisome proliferator-activated receptor (PPAR)γ activation protects against tumourigenesis, results from a few clinical trials using PPARγ ligands as monotherapy show modest success. …”
    Get full text
    Article
  3. 243

    Application of Surface Roughness Analysis on Micro–Computed Tomographic Images of Bone Erosion: Examples Using a Rodent Model of Rheumatoid Arthritis by Matthew D. Silva, Jason Ruan, Elizabeth Siebert, Anneli Savinainen, Bruce Jaffee, Lisa Schopf, Sudeep Chandra

    Published 2006-10-01
    “…Quantifying the bone erosion in preclinical models of rheumatoid arthritis is valuable for the evaluation of drug treatments. …”
    Get full text
    Article
  4. 244

    Practical Vessel Imaging by Computed Tomography in Live Transgenic Mouse Models for Human Tumors by Gordon L. Kindlmann, David M. Weinstein, Greg M. Jones, Christopher R. Johnson, Mario R. Capecchi, Charles Keller

    Published 2005-10-01
    “…This study lays a groundwork for the qualitative and quantitative assessment of anti-angiogenesis preclinical studies using transgenic mice.…”
    Get full text
    Article
  5. 245

    Mesenchymal Stem Cells and Cutaneous Wound Healing: Current Evidence and Future Potential by M. Isakson, C. de Blacam, D. Whelan, A. McArdle, A. J. P. Clover

    Published 2015-01-01
    “…This review examines the body of evidence suggesting that MSC accelerate wound healing in both clinical and preclinical studies and also the possible mechanisms controlling its efficacy. …”
    Get full text
    Article
  6. 246

    Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy by Maurizio Ceppi, Bruno Gomes, Simon Deycmar, Jehad Charo, J Mark Cline

    Published 2023-01-01
    “…The complexity of cancer immunotherapy (CIT) demands reliable preclinical models to successfully translate study findings to the clinics. …”
    Get full text
    Article
  7. 247

    Measuring Brain Tumor Growth: Combined Bioluminescence Imaging–Magnetic Resonance Imaging Strategy by Sarah C. Jost, Lynne Collins, Sarah Travers, David Piwnica-Worms, Joel R. Garbow

    Published 2009-09-01
    “…The results led us to suggest a cost-effective, multimodality strategy for selecting cohorts of animals with similar tumor growth patterns that improves the accuracy of longitudinal in vivo measurements of tumor growth and treatment response in preclinical therapeutic studies.…”
    Get full text
    Article
  8. 248

    Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome by Jibin Han, Yanmin Li, Yuanyuan Li

    Published 2019-01-01
    “…Accordingly, several strategies have been explored to improve MSC retention in the lung and enhance the innate properties of MSCs in preclinical models of ARDS. To provide a comprehensive and updated view, we summarize a large body of experimental evidence for a variety of strategies directed towards strengthening the therapeutic potential of MSCs in ARDS.…”
    Get full text
    Article
  9. 249

    Recent Advances, Research Trends, and Clinical Relevance of Hyaluronic Acid Applied to Wound Healing and Regeneration by Gloria Huerta-Ángeles, Edgar Mixcoha

    Published 2025-01-01
    “…This review reports many of the latest developments of hyaluronan and its derivatives in research, preclinical, and published clinical trials for wound healing. …”
    Get full text
    Article
  10. 250
  11. 251

    African animal trypanocide resistance: A systematic review and meta-analysis by Keneth Iceland, Kasozi, Ewan, Thomas MacLeod, Susan, Christina Welburn

    Published 2023
    “…To address resistance, most preclinical studies increased the dosage and the treatment time, and this failed to improve the patient’s prognosis. …”
    Get full text
    Article
  12. 252

    Comparison Study of Airway Reactivity Outcomes due to a Pharmacologic Challenge Test: Impulse Oscillometry versus Least Mean Squared Analysis Techniques by Elena Rodriguez, Charrell M. Bullard, Milena H. Armani, Thomas L. Miller, Thomas H. Shaffer

    Published 2013-01-01
    “…The present study represents a preclinical animal study to determine whether these respiratory function techniques (LMS and IOS) are comparable in detecting changes in respiratory resistance derived from a direct pharmacological challenge.…”
    Get full text
    Article
  13. 253

    Epigenetic Drug Interventions in Breast Cancer: A Narrative Review of Current Research and Future Directions by Sarah Bibi Mungly, Evelyn Priya Peter, Ling-Wei Hii, Chun-Wai Mai, Felicia Fei-Lei Chung

    Published 2024-09-01
    “…In this review, we summarise and present the preclinical and clinical evidence for epigenetic drugs in treating breast cancer. …”
    Get full text
    Article
  14. 254

    Oligonucleotides as a Novel Therapeutic Approach: An Innovative Area for Drug Delivery in Neurological Disorders by Yasir Qasim Almajidi, Rana Kadum Muslim, Yaseen T. khalf

    Published 2025-01-01
    “…The current review provides an update on novel approaches, preclinical, clinical evidence, and delivery route of ASOs. …”
    Get full text
    Article
  15. 255

    The Potential of Curcumin in Treatment of Spinal Cord Injury by Raghavendra Sanivarapu, Vijayalakshmi Vallabhaneni, Vivek Verma

    Published 2016-01-01
    “…We critically and systematically summarize available data, discuss clinical implications, and propose further testing of this well-tolerated compound in both the preclinical and the clinical realms. Analyzing preclinical data from a clinical perspective, we hope to create awareness of the incredible potential that curcumin shows for SCI in a patient population that direly needs improvements on current therapy.…”
    Get full text
    Article
  16. 256

    Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges by Claire MacNabb, D. Patton, J. S. Hayes

    Published 2016-01-01
    “…In anticipation of phase III trial results which may potentially signify a significant step in achieving market approval here, we review the preclinical and clinical emergence of sclerostin antibody therapies for both osteoporosis and alternative applications. …”
    Get full text
    Article
  17. 257

    Hubungan antara Kebiasaan Olahraga dengan Dismenore pada Mahasiswi Pre-Klinik Program Studi Pendidikan Dokter Fakultas Kedokteran Universitas Andalas Tahun Ajaran 2012 - 2013 by Ayu Anissa Bahri, Afriwardi , Yusrawati

    Published 2015-09-01
    “…The population of this study were all female preclinical students of Medical Faculty Andalas University in academic<br />year 2012-2013. …”
    Get full text
    Article
  18. 258

    Establishment and characterization of a new mouse gastric carcinoma cell line, MCC by Yushen Wang, Xianju Li, Yi Wang, Jun Qin

    Published 2025-01-01
    “…By integrating proteomic profiles from clinical gastric cancer patients and the murine subcutaneous tumor model, several molecular targets suitable for preclinical investigation were identified. Trametinib, a MEK inhibitor, was employed as a model compound in our preclinical study. …”
    Get full text
    Article
  19. 259
  20. 260

    Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects by Zhipeng Cao, Sadia Quazi, Sakshi Arora, Laura D. Osellame, Ingrid J. Burvenich, Peter W. Janes, Andrew M. Scott

    Published 2025-01-01
    “…Notably, cancer-associated fibroblasts (CAFs) have emerged as one of the primary contributors in shaping TME, creating a favourable environment for cancer development. Many preclinical studies have identified promising targets on CAFs, demonstrating remarkable efficacy of some CAF-targeted treatments in preclinical models. …”
    Get full text
    Article